Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study. - Crowley, Jeffrey J.; Langley, Richard G.; Gordon, Kenneth B.; Pinter, Andreas; Ferris, Laura K.; Rubant, Simone; Photowala, Huzefa; Xue, Zhenyi; Wu, Tianshuang; Zhan, Tianyu; Beeck, Stefan; Shah, Megha; et al. (Dermatology & Therapy, 2022)